Aethlon Medical, Inc. (NASDAQ:AEMD) Q3 2026 Earnings Call Transcript February 12, 2026 Aethlon Medical, Inc. misses on ...

Need a quote from a Motley Fool analyst? Revenue guidance for 2026 -- $80 million to $85 million, implying 12%-19% ...

Chief Executive Officer — Eric Schlorff Chief Commercial Officer — Tim Varacek Chief Medical Officer — Kevin Chung Controller — Brad Town Investor Relations — Jackie Cossmon Chief Medical Officer ...

At this time, I would like to welcome everyone to the Inspire Medical Systems, Inc. fourth quarter and full year 2025 conference call. Ezgi Yagci: Thank you, Delam, and thank you all for participating ...

Good morning, and welcome to Rockwell Medical's Fourth Quarter and Full Year 2024 Results Conference Call and Webcast. Please note, this event is being recorded. At this time, I would like to turn the ...

Management confirmed that the integration of newly acquired CyVantage assets is largely complete, enabling execution of the simultaneous launch strategies for Catamaran SE and the Symmetry Plus ...

NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Q1 2026 Earnings Call Transcript February 17, 2026 NeuroOne Medical Technologies Corporation beats earnings expectations. Reported EPS is $-0.03 ...

AVITA Medical, Inc. misses on earnings expectations. Reported EPS is $-0.53 EPS, expectations were $-0.39. Operator: Good day, and thank you for standing by. Welcome to AVITA Medical First Quarter ...

Good morning and welcome to the Q3 2024 Medical Properties Trustearnings conference call All participants will be in listen-only mode. [Operator instructions] After today's presentation, there will be ...

IceCure Medical Ltd (NASDAQ: ICCM) Q4 2024 Earnings Call Transcript March 27, 2025 IceCure Medical Ltd misses on earnings expectations. Reported EPS is $-0.08 EPS, expectations were $-0.07. Operator: ...

Good afternoon, and welcome to the Aethlon Medical First Quarter Fiscal 2026 Earnings and Corporate Update. Please note this event is being recorded. I would now like to turn the conference over to ...

Revenue-- $564,000 in revenue for fiscal Q2 2025 (period ended June 30, 2025), down from $901,000 in fiscal Q2 2024, reflecting a reduction attributed to lower procedure volumes and a shift in ...